AmerisourceBergen Corporation (ABC) financial statements (2022 and earlier)

Company profile

Business Address 1 WEST FIRST AVENUE
CONSHOHOCKEN, PA 19428
State of Incorp. DE
Fiscal Year End September 30
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,1692,5474,5983,3742,4932,4352,742
Cash and cash equivalents3,1692,5474,5983,3742,4932,4352,742
Receivables17,32918,38914,33512,38711,31410,3039,176
Inventory, net of allowances, customer advances and progress billings16,29415,36812,58911,06011,91911,46110,724
Inventory16,29415,36812,58911,06011,91911,46110,724
Disposal group, including discontinued operation373373     
Other undisclosed current assets2,2142,1251,5341,311169103210
Total current assets:39,37938,80333,05628,13225,89424,30322,852
Noncurrent Assets
Property, plant and equipment2,1302,1631,4851,7711,8921,7981,531
Intangible assets, net (including goodwill)14,00214,2878,5939,0009,6128,8788,959
Goodwill8,9229,0316,7076,7066,6646,0445,991
Intangible assets, net (excluding goodwill)5,0815,2571,8862,2952,9482,8332,968
Deferred income tax assets270291362 
Other noncurrent assets1,7961,794780269271338314
Total noncurrent assets:18,19918,53511,21911,04011,77511,01310,804
TOTAL ASSETS:57,57857,33844,27539,17237,67035,31633,656
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41,16040,86633,35229,44227,71826,80624,670
Accounts payable38,61838,01031,70528,38526,83725,40423,926
Accrued liabilities2,5422,8561,6471,0578811,402744
Debt26930050113915212611
Disposal group, including discontinued operation185192     
Total current liabilities:41,61441,35933,85329,58127,87026,81825,281
Noncurrent Liabilities
Long-term debt and lease obligation6,4136,3843,6184,0344,5113,7823,870
Long-term debt, excluding current maturities6,4136,3843,6184,0344,1593,4303,594
Capital lease obligations352352276
Liabilities, other than long-term debt8,9509,0117,6432,2434101602,375
Accounts payable and accrued liabilities289281285284300  
Deferred tax liabilities, net  2,215
Deferred income tax liabilities1,6891,6856861,860
Estimated litigation liability5,9115,9626,199    
Other liabilities1,0601,08347399110160160
Other undisclosed noncurrent liabilities   3211,829  
Total noncurrent liabilities:15,36315,39511,2616,5976,7503,9416,245
Total liabilities:56,97656,75345,11436,17934,62030,75931,527
Stockholders' equity
Stockholders' equity attributable to parent242223(1,019)2,8792,9332,0642,129
Common stock3333333
Treasury stock, value(6,504)(6,470)(6,513)(6,098)(5,427)(4,755)(4,396)
Additional paid in capital5,5475,4655,0824,8504,7154,5184,333
Accumulated other comprehensive loss(823)(445)(109)(112)(79)(96)(114)
Retained earnings2,0191,6715184,2353,7212,3952,304
Stockholders' equity attributable to noncontrolling interest360361179114117  
Total stockholders' equity:601584(840)2,9933,0502,0642,129
Other undisclosed liabilities and equity     2,493 
TOTAL LIABILITIES AND EQUITY:57,57857,33844,27539,17237,67035,31633,656

Income statement (P&L) ($ in millions)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Revenues221,101213,989189,894179,589167,940153,144146,850
Cost of revenue
(Cost of Goods and Services Sold)
(213,550)(207,046)(184,702)(174,451)(163,327)(148,598)(142,577)
Gross profit:7,5516,9435,1925,1384,6124,5464,273
Operating expenses(5,231)(4,571)(10,327)(4,026)(3,109)(3,486)(2,606)
Other undisclosed operating income (loss)131(18)  (60) (140)
Operating income (loss):2,4512,354(5,135)1,1121,4441,0601,526
Nonoperating income (expense)3342213(25)35
Investment income, nonoperating   14   
Foreign currency transaction gain (loss), before tax5(3)     
Interest and debt expense (10)(22)(7)(24)(6)(6)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes24 (138)(151)(217)(139)(134)
Income (loss) from continuing operations before equity method investments, income taxes:2,5082,386(5,294)9671,1779181,391
Other undisclosed loss from continuing operations before income taxes(218)(164)     
Income (loss) from continuing operations before income taxes:2,2902,222(5,294)9671,1779181,391
Income tax expense (benefit)(675)(677)1,894(113)438(553)37
Net income (loss):1,6151,545(3,400)8541,6163641,428
Net income (loss) attributable to noncontrolling interest(1)(5)(9)143  
Net income (loss) available to common stockholders, diluted:1,6141,540(3,409)8551,6583641,428

Comprehensive Income ($ in millions)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Net income (loss):1,6151,545(3,400)8541,6163641,428
Other comprehensive income (loss)(758)(335)(9)(33)81822
Comprehensive income (loss):8581,210(3,409)8211,6243831,450
Comprehensive income (loss), net of tax, attributable to noncontrolling interest4(7)3251  
Comprehensive income (loss), net of tax, attributable to parent:8621,203(3,406)8231,6753831,450

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: